journal article·2022-09-28Open access

On-Demand Release of Fucoidan from a Multilayered Nanofiber Patch for the Killing of Oral Squamous Cancer Cells and Promotion of Epithelial Regeneration

Yingnan Liu, Yingjie Xu, Xiaopei Zhang, Na Liu, Beibei Cong, Yu Sun, Mingxia Guo, Zeyu Liu, Le Jiang, Wanchun Wang, Tong Wu, Yuanfei Wang

Abstract

Oral squamous cell carcinoma represents 90% of all oral cancers. Recurrence prevention remains an important prognostic factor in patients with oral squamous cell carcinoma, and the recovery of the oral epithelium post-surgery is still a challenge. Thus, there is an urgent need to develop a smart carrier material to realize the spatiotemporally controlled release of anticancer drugs, instead of multiple oral administrations, for recurrence prevention and promoting the reconstruction of injured epithelial tissues. Here, we developed a multi-layered nanofiber patch capable of the photothermal-triggered release of low-molecular-weight fucoidan (LMWF) from the sandwiched layer, together with electrospun fibers as the backing and top layers. The sandwiched layer was made of phase-change materials loaded with indocyanine green, a photosensitive dye, for the localized release of LMWF in response to near-infrared irradiation. We showed that the on-demand release of LMWF was able to kill oral cancer cells effectively. Furthermore, adding acellular dermal matrix to the top nanofiber layer improved the proliferation of human oral keratinocytes, while the hydrophobic back layer served as a barrier to prevent loss of the drug. Taken together, this study provides a feasible and smart material system for killing oral squamous cancer cells together with the recovery of oral epithelium.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Seaweed-derived Bioactive Compounds · Nanoplatforms for cancer theranostics · Corneal Surgery and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Neuroregeneration and Neurorehabilitation, Qingdao Medical College, Qingdao University, Qingdao 266071, China

Qingdao Stomatological Hospital, Qingdao 266001, China

Shandong Key Laboratory of Medical and Health Textile Materials, Collaborative Innovation Center for Eco-Textiles of Shandong Province and the Ministry of Education, 308 Ningxia Road, Qingdao 266071, China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Shandong Province · Traditional Chinese Medicine Science and Technology Project of Shandong province · Young Elite Scientists Sponsorship Program by CAST · Qingdao Health Science and Technology Plan Project · Qingdao Key Health Discipline Development Fund (2020–2022), and Qingdao Clinical Research Center for Oral Diseases

References (47)

Show source-provided references
1. The role of MMP-2 and MMP-9 as prognostic markers in the early stages of tongue squamous cell carcinoma10.1111/jop.12245 ↗
2. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world10.1200/JCO.2005.05.2308 ↗
3. In vivo and in vitro effects of curcumin on head and neck carcinoma: A systematic review10.1111/jop.12455 ↗
4. Oral Squamous Cell Carcinoma: Current Treatment Strategies and Nanotechnology-Based Approaches for Prevention and Therapy10.1615/CritRevTherDrugCarrierSyst.2016016272 ↗
5. The molecular biology of head and neck cancer10.1038/nrc2982 ↗
6. Increased survival rate by local release of diclofenac in a murine model of recurrent oral carcinoma10.2147/IJN.S109199 ↗
7. Antimicrobial Chitosan based formulations with impact on different biomedical applications10.2174/138920101602150112151157 ↗
8. Croitoru, A.M., Karaçelebi, Y., Saatcioglu, E., Altan, E., Ulag, S., Aydoğan, H.K., Sahin, A., Motelica, L., Oprea, O., and Tihauan, B.M. (2021). Electrically Triggered Drug Delivery from Novel Electrospun Poly(Lactic Acid)/Graphene Oxide/Quercetin Fibrous Scaffolds for Wound Dressing Applications. Pharmaceutics, 13.10.3390/pharmaceutics13070957 ↗
9. Croitoru, A.M., Moroșan, A., Tihăuan, B., Oprea, O., Motelică, L., Trușcă, R., Nicoară, A.I., Popescu, R.C., Savu, D., and Mihăiescu, D.E. (2022). Novel Graphene Oxide/Quercetin and Graphene Oxide/Juglone Nanostructured Platforms as Effective Drug Delivery Systems with Biomedical Applications. Nanomaterials, 12.10.3390/nano12111943 ↗
10. Use of asymmetric multilayer polylactide nanofiber mats in controlled release of drugs and prevention of liver cancer recurrence after surgery in mice10.1016/j.nano.2015.03.001 ↗
11. Functional Electrospun Fibers for Local Therapy of Cancer10.1007/s42765-020-00053-9 ↗
12. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids10.1021/ja200328s ↗
13. ATP-triggered anticancer drug delivery10.1038/ncomms4364 ↗
14. Cholinesterase-responsive supramolecular vesicle10.1021/ja303280r ↗
15. Thermally Responsive Hydrogel Blends: A General Drug Carrier Model for Controlled Drug Release10.1002/anie.201501705 ↗
16. Lipid-peptide vesicle nanoscale hybrids for triggered drug release by mild hyperthermia in vitro and in vivo10.1021/nn302148p ↗
17. A controlled-release microchip10.1038/16898 ↗
18. Conducting-Polymer Nanotubes for Controlled Drug Release10.1002/adma.200501726 ↗
19. Singh, A.V., Chandrasekar, V., Laux, P., Luch, A., Dakua, S.P., Zamboni, P., Shelar, A., Yang, Y., Pandit, V., and Tisato, V. (2022). Micropatterned Neurovascular Interface to Mimic the Blood–Brain Barrier’s Neurophysiology and Micromechanical Function: A BBB-on-CHIP Model. Cells, 11.10.3390/cells11182801 ↗
20. Construction of Electrospun Organic/Inorganic Hybrid Nanofibers for Drug Delivery and Tissue Engineering Applications10.1007/s42765-019-00007-w ↗
21. A new theranostic system based on gold nanocages and phase-change materials with unique features for photoacoustic imaging and controlled release10.1021/ja200894u ↗
22. UV and near-IR triggered release from polymeric nanoparticles10.1021/ja102595j ↗
23. Gold nanocages covered by smart polymers for controlled release with near-infrared light10.1038/nmat2564 ↗
24. The Smart Drug Delivery System and Its Clinical Potential10.7150/thno.14858 ↗
25. Stimuli-responsive nanomaterials for biomedical applications10.1021/ja510147n ↗
26. Stimuli-responsive nanocarriers for drug delivery10.1038/nmat3776 ↗
27. Photoresponsive nanoparticles for drug delivery10.1016/j.nantod.2015.06.004 ↗
28. A temperature-sensitive drug release system based on phase-change materials10.1002/anie.201004057 ↗
29. Microscale polymer bottles corked with a phase-change material for temperature-controlled release10.1002/anie.201305006 ↗
30. Emerging applications of phase-change materials (PCMs): Teaching an old dog new tricks10.1002/anie.201305201 ↗
31. Transporting mitochondrion-targeting photosensitizers into cancer cells by low-density lipoproteins for fluorescence-feedback photodynamic therapy10.1039/D0NR07342C ↗
32. Bringing naturally-occurring saturated fatty acids into biomedical research10.1039/D1TB00843A ↗
33. A Sensitive and Reliable Organic Fluorescent Nanothermometer for Noninvasive Temperature Sensing10.1021/jacs.1c04597 ↗
34. A Hybrid Nanomaterial for the Controlled Generation of Free Radicals and Oxidative Destruction of Hypoxic Cancer Cells10.1002/anie.201702898 ↗
35. Integration of Phase-Change Materials with Electrospun Fibers for Promoting Neurite Outgrowth under Controlled Release10.1002/adfm.201705563 ↗
36. Combination cancer treatment through photothermally controlled release of selenous acid from gold nanocages10.1016/j.biomaterials.2018.03.058 ↗
37. A Eutectic Mixture of Natural Fatty Acids Can Serve as the Gating Material for Near-Infrared-Triggered Drug Release10.1002/adma.201703702 ↗
38. A comparative study of antithrombotic and antiplatelet activities of different fucoidans from Laminaria japonica10.1016/j.thromres.2011.07.041 ↗
39. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor10.1016/j.exer.2013.06.011 ↗
40. Influence of fucoidans on hemostatic system10.3390/md11072444 ↗
41. Enzyme-digested Fucoidan Extracts Derived from Seaweed Mozuku of Cladosiphon novae-caledoniae kylin Inhibit Invasion and Angiogenesis of Tumor Cells10.1007/s10616-005-3761-8 ↗
42. Induction of apoptosis by low-molecular-weight fucoidan through calcium- and caspase-dependent mitochondrial pathways in MDA-MB-231 breast cancer cells10.1271/bbb.120631 ↗
43. Luthuli, S., Wu, S., Cheng, Y., Zheng, X., Wu, M., and Tong, H. (2019). Therapeutic Effects of Fucoidan: A Review on Recent Studies. Mar. Drugs, 17.10.3390/md17090487 ↗
44. Antimetastatic Effect of Fucoidan-Sargassum against Liver Cancer Cell Invadopodia Formation via Targeting Integrin αVβ3 and Mediating αVβ3/Src/E2F1 Signaling10.7150/jca.26740 ↗
45. Effect of fucoidan from Turbinaria conoides on human lung adenocarcinoma epithelial (A549) cells10.1016/j.carbpol.2016.06.112 ↗
46. Effects of Low Molecular Weight Fucoidan on the Proliferation and Apoptosis of Dysplastic Oral Keratinocyte and Oral Squamous Cell Carcinoma Cells
47. Interfacial Water in the SARS Spike Protein: Investigating the Interaction with Human ACE2 Receptor and In Vitro Uptake in A549 Cells10.1021/acs.langmuir.2c00671 ↗